Catherine Jeter, PA-C

Catherine Jeter practices at Alpesh D. Desai, D.o. P.a. in Houston, Texas.

Catherine Jeter's NPI, 1881152775, was assigned on March 9, 2019. Catherine Jeter holds California license PA60561.

Catherine Jeter's primary practice is Alpesh D. Desai, D.o. P.a., at 2120 Ashland St, Houston, TX 77008-2418. The practice phone is (713) 864-2659.

Catherine Jeter's primary practice is Alpesh D. Desai, D.o. P.a. in Houston, Texas. The medical group on file is Heights Dermatology And Aesthetic Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Catherine Jeter practices. Vendor and product names are available with a free account.

Physician assistant is Catherine Jeter's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Catherine Jeter is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, psoriasis, rash and scalp rash among the conditions Catherine Jeter treats.

CMS data shows 808 Medicare services from Catherine Jeter across 8 procedure codes in 2024, for 237 Medicare patients. Medicare paid $28,133 for them. Every service was in an office.

CMS counts 237 Medicare patients who saw Catherine Jeter in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Catherine Jeter's median patient age at 68, with 29% women.

In 2024, Catherine Jeter wrote 228 Medicare Part D claims for 97 patients. 84% of them were for generic drugs. CMS names the drug for 133 of them, across 5 drugs with 11 or more claims each, at $64,921 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Catherine Jeter for performance year 2024, reported as part of a group. Catherine Jeter accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 51 general payments to Catherine Jeter from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 86% of the total. Janssen Pharmaceuticals, Inc paid the most, $396.